IMMUNOGENETICS OF HYBRID RESISTANCE
混合抗性的免疫遗传学
基本信息
- 批准号:3174580
- 负责人:
- 金额:$ 27.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-03-01 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:antibody dependent killer cell autoimmune disorder bone marrow transplantation cell fusion cell mediated lymphocytolysis test chromosome walking clone cells flow cytometry gene dosage gene expression genetic mapping genetic regulation genetically modified animals graft versus host disease haploidy heterozygote histocompatibility histocompatibility antigens immune tolerance /unresponsiveness immunogenetics immunoglobulins immunoregulation laboratory mouse laboratory rat major histocompatibility complex microorganism genetics molecular cloning monoclonal antibody neoplasm /cancer immunology newborn animals nucleic acid probes radiation immunosuppression restriction fragment length polymorphism structural genes transfection
项目摘要
The long-term goal is to determine the genetic mechanism of expression of
Hemopoietic histocompatibility (Hh) antigens on the surface of leukemic and
normal progenitor cells and characterize the Hh molecules themselves. To
that end the following Aims are described: 1. Confirm the conclusion that
Hh antigenic expression on lymphoma cells is "down-regulated" by
trans-acting regulatory genes. Using both in vivo and in vitro assays for
hybrid resistance in which "cold target cells competition" can be measured,
we observed that ACCb H-2d/H-2b loss mutants which had lost Dd gained the
expression of Hhb. 2. Map the Hh genes more precisely. B10.RQDB is a new
H-2 recombinant described by Chella David, which expresses Dd, Db, but not
Ld. Therefore, recombination occurred between D and L and Db is really
Lb. The marrow cells have lost Hhb, retained Hhd for allogenic hosts and
have decreased Hhd for F1 hybrid hosts. There and other new recombinants
will be used to map Hh, which should be contromeric to L since the sequence
is D (R) L in the D-region. (3) Test the cis gene hypothesis, i.e. an
adjacent gene regulates Hh expression. Use same new H-2 recombination to
detect gene(s) between S and L which may regulate Hh expression in
heterozygotes that regulated "tolerance" to parental Hh antigen. (4)
Continue to test the "allogenic inhibition" hypothesis for hybrid
resistance. Marrow cells from C.B-17 scid/scid donors, which cannot
generate alloreactive T or B cells, nevertheless are rejected by irradiated
allogeneic or F1 hybrid recipient mice. (5) Characterize Hh molecules.
2-D gels of lysates of 35S-methionine labeled EL-4 and various ACCb cell
lines, followed by computer analysis of radiographs, identified a 90 kd
molecule as a potential candidate for the Hhb antigen. We will generate
antibodies to isolate the molecules, and study its structure.
长期目标是确定表达的遗传机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Bennett其他文献
Michael Bennett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Bennett', 18)}}的其他基金
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
阻断 NK 细胞的负信号来治疗白血病
- 批准号:
6376235 - 财政年份:2000
- 资助金额:
$ 27.11万 - 项目类别:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
阻断 NK 细胞的负信号来治疗白血病
- 批准号:
6633105 - 财政年份:2000
- 资助金额:
$ 27.11万 - 项目类别:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
阻断 NK 细胞的负信号来治疗白血病
- 批准号:
6131639 - 财政年份:2000
- 资助金额:
$ 27.11万 - 项目类别:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
阻断 NK 细胞的负信号来治疗白血病
- 批准号:
6512815 - 财政年份:2000
- 资助金额:
$ 27.11万 - 项目类别:
INTERNATIONAL CONFERENCE ON THE CEROID-LIOPFUSCINOSES
蜡质-脂褐质国际会议
- 批准号:
2723292 - 财政年份:1998
- 资助金额:
$ 27.11万 - 项目类别:
BLOCKING NEGATIVE SIGNALS TO NK CELLS TO TREAT LEUKEMIA
阻断 NK 细胞的负信号来治疗白血病
- 批准号:
2390914 - 财政年份:1996
- 资助金额:
$ 27.11万 - 项目类别:
相似海外基金
Autoimmune disorder in hereditary angioedema
遗传性血管性水肿中的自身免疫性疾病
- 批准号:
26460654 - 财政年份:2014
- 资助金额:
$ 27.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of lymphocyte transmigration across the blood-brain barrier using an in vitro model that mimics blood flow and simulates inflammatory conditions as observed in the most frequent autoimmune disorder of the central nervous system, multiple sclero
使用体外模型模拟血流并模拟在中枢神经系统最常见的自身免疫性疾病多发性硬化症中观察到的炎症状况,从而研究淋巴细胞跨血脑屏障的迁移机制
- 批准号:
235301825 - 财政年份:2013
- 资助金额:
$ 27.11万 - 项目类别:
Research Fellowships
The challenge for the development of therapy for autoimmune disorder by the establishment of artificial thymic medullary organ
人工胸腺髓质器官的建立对自身免疫性疾病治疗发展的挑战
- 批准号:
23659241 - 财政年份:2011
- 资助金额:
$ 27.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research